Clin2
NCT06731023Possibly a fitNot yet recruiting

Treating Stubborn H. pylori with Tailored Bismuth Quadruple Therapy

HELICOBACTER PYLORI INFECTIONS

Treatments studied

Part of Digestive system, Infections clinical trials.

This study tests whether a 14-day treatment with bismuth and four drugs, chosen based on lab tests showing which antibiotics still work, can clear an extremely stubborn H. pylori infection that hasn't gone away after at least two prior treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You are between 18 and 65 years old.
  • You have an H. pylori infection that has been confirmed by a breath test or stomach biopsy.
  • You have already tried at least two standard treatments for H. pylori, and those treatments included at least three different antibiotics that are not likely to cause resistance.
  • You do not have serious health problems like severe liver or kidney disease, a weak immune system, cancer, or significant heart disease.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study, and you agree to use birth control if needed.
  • You have not taken bismuth, antibiotics, or acid-reducing drugs in the last 4 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06723197Recruiting· Phase 4
Comparing treatment lengths for H. pylori infection

This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.

Jinan, Shandong
NCT07179159Recruiting
14-day stomach infection treatment study

This study compares two treatments for an H. pylori stomach infection: taking two medicines (vonoprazan and amoxicillin) versus taking four medicines. Both treatments are given for 14 days.

Jinan, Shandong
NCT07576959Recruiting· Phase 3
Bismuth with dual therapy for H. pylori infection treatment

This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.

Taipei
NCT07533422Not yet recruiting
Testing stool to treat stubborn stomach bacteria

This study helps people whose H. pylori stomach infection didn't go away after their first round of antibiotics. Researchers will test your stool to find which antibiotics work best, then prescribe a personalized treatment plan.

NCT07142798Enrolling by invitation
14-day triple therapy for H. pylori infection

This trial tests a 14-day treatment using bismuth, amoxicillin, and a stomach acid reducer (PCAB) to see how well it clears H. pylori, a bacteria that can cause stomach ulcers. It may be an option if you have H. pylori and haven't had stomach surgery or certain serious health conditions.

Kaohsiung City
NCT07574983Not yet recruiting
Two antibiotic treatments for stomach bacteria infection

This study compares two different antibiotic regimens to eliminate Helicobacter pylori, a common stomach bacterium that can cause ulcers and digestive problems. You'll be randomly assigned to receive one of two treatment approaches and followed to see which works better.

Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.